Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Avalo Therapeutics, Inc. (CERC) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2023 SC 13G/A Caissa Capital Management ltd. reports a 0% stake in Avalo Therapeutics, Inc.
04/19/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Nantahala Capital Management, LLC reports a 7% stake in AVALO THERAPEUTICS, INC.
02/14/2023 SC 13G/A Caissa Capital Management ltd. reports a 10.6% stake in Avalo Therapeutics, Inc.
08/08/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A Point72 Asset Management, L.P. reports a 5.4% stake in Avalo Therapeutics, Inc.
02/14/2022 SC 13G/A Nantahala Capital Management, LLC reports a 7.5% stake in AVALO THERAPEUTICS, INC.
02/14/2020 SC 13G/A Opaleye Management Inc. reports a 4.2% stake in CERECOR INC.
02/14/2019 SC 13G/A Opaleye Management Inc. reports a 5.4% stake in CERECOR INC.
02/15/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2017 SC 13G/A New Enterprise Associates 14, L.P. has filed a Schedule 13D for Cerecor Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy